Yerevan, Armenia

Arsenii Sokolov

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Bostongene Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arsenii Sokolov. Retrieved from https://idiyas.com/inventor/arsenii-sokolov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arsenii Sokolov: Innovator in Cancer Immunoprofiling

Introduction

Arsenii Sokolov is an inventor based in Yerevan, Armenia. He is focused on developing innovative methods for cancer immunoprofiling. Although he currently holds no granted patents, his work is significant in the field of cancer research.

Latest Patent Applications

Arsenii Sokolov has submitted several notable patent applications. One of his latest applications is titled "COMPREHENSIVE IMMUNOPROFILING OF PERIPHERAL BLOOD." This application relates to methods, systems, and computer-readable storage media that are useful for characterizing subjects with cancer. The disclosure is based on methods for immunoprofiling a cancer subject and assessing the subject's prognosis and likelihood of responding to immunotherapy based on the analysis of leukocyte populations in the peripheral blood. Another application is "FLOW CYTOMETRY IMMUNOPROFILING OF PERIPHERAL BLOOD," which shares similar objectives and methodologies as the previous application.

Conclusion

Arsenii Sokolov is making strides in the field of cancer immunoprofiling through his innovative patent applications. His work has the potential to significantly impact cancer treatment and patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…